INHALATION THERAPY IN CHILDREN: ISSUES AND OPTIONS

INHALATION THERAPY IN CHILDREN: ISSUES AND OPTIONS

Today inhalation therapy forms the basis of treatment for children and adults with bronchial asthma. In the current market there is a great number of various drug delivery systems, such as: nebulisers, pressurised metered-dose inhalers and dry powder inhalers. Guidelines for diagnosis and management...

Full description

Saved in:

Bibliographic Details
Main Authors:	L. R. Selimzyanova, E. А. Promyslova, E. А. Vishnyeva
Format:	Article
Language:	English
Published:	"Paediatrician" Publishers LLC 2014-03-01
Series:	Вопросы современной педиатрии
Subjects:	children inhalation therapy bronchial asthma dry powder inhalers easyhaler
Online Access:	https://vsp.spr-journal.ru/jour/article/view/211
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

MEANS OF DRUG DELIVERY IN THE EVENT OF INHALATION THERAPY IN CHILDREN: SELECTION CRITERIA
by: L. R. Selimzyanova, et al.
Published: (2014-09-01)

Technical evaluation of Turbuhaler® use in children with bronchial asthma: combination of a checklist and inhalation parameters
by: Lina Liang, et al.
Published: (2025-08-01)

Comparison of the Correct Use of Different Types of Inhalers in Patients with COPD and Bronchial Asthma
by: A. A. Vizel, et al.
Published: (2023-07-01)

Influence of polymorphism of the gene of inducible NO-synthase on the achievement of control of bronchial asthma in children against the background of inhalation corticosteroid therapy
by: I. Yu. Smirnova, et al.
Published: (2009-08-01)

Evaluation of Inhaler Technique in Patients with Asthma and Chronic Obstructive Pulmonary Disease in Andaman and Nicobar Islands – An Observational Study
by: M. Natraj, et al.
Published: (2025-01-01)

COMPARATIVE EFFICACY OF INHALED DRUGS FORMOTEROL / BECLOMETHASONE AND FORMOTEROL / BUDESONIDE AND BRONCHIAL ASTHMA
by: V. A. Nikitin, et al.
Published: (2016-03-01)

Effective inhaler technique education is achievable - assessment and comparison of five inhaler devices errors
by: Monika Marko, et al.
Published: (2025-04-01)

Validation of an AI-Powered Smart Dry Powder Inhaler (RS01X) for Asthma and COPD in a Clinical Setting
by: Chamaon D, et al.
Published: (2025-03-01)

Treatment with oral or inhaled bronchodilator without inhaled corticosteroids in bronchial asthma: A dangerous weapon!
by: Shital Patil, et al.
Published: (2023-05-01)

PEDIATRIC BRONCHIAL ASTHMA: MODERN TREATMENT ASPECTS
by: O.V. Zaitseva, et al.
Published: (2011-11-01)

Spore-inspired inhalation drug delivery system for asthma therapy
by: Mengqi Tong, et al.
Published: (2025-11-01)

Barriers to Inhaler Adherence in Asthmatic Children and Outcome After Intervention
by: Vineeta Pande, et al.
Published: (2024-11-01)

Evaluation of asthma control after reinforcement of proper inhaler techniques in a tertiary care center in northern India
by: Manav Raj Singh Gill, et al.
Published: (2024-10-01)

Oral health status of asthmatic children using inhaled corticosteroids
by: Münevver Doğan, et al.
Published: (2021-02-01)

PNEUMONIA IN PATIENTS WITH BRONCHO-OBSTRUCTIVE DISEASES TREATED WITH INHALED GLUCOCORTICOSTEROIDS
by: E. A. Kulagin, et al.
Published: (2017-06-01)

CICLESONIDE IN TREATMENT OF CHILDHOOD BRONCHIAL ASTHMA
by: K. E. Efendieva, et al.
Published: (2013-02-01)

THE MORPHOLOGICAL PATTERN OF BRONCHIAL WALL AT THE PLACE OF RESECTION IN PULMONARY TUBERCULOSIS PATIENTS AFTER PERIBRONCHIAL LYMPHOTROPIC OR INHALATION THERAPY
by: K. A. Аvdienko, et al.
Published: (2019-01-01)

Prevalence and predictors of suboptimal peak inspiratory flow rates in the management of chronic obstructive pulmonary disease
by: Madhusmita Mohanty Mohapatra, et al.
Published: (2024-12-01)

Comparison of clinical outcome of COPD with asthma-like feature with different inhalation therapies: a real-world study in the prospective RealDTC cohort
by: Ling Lin, et al.
Published: (2025-07-01)

Development of an AI-Empowered Novel Digital Monitoring System for Inhalation Flow Profiles
by: Ziyi Fan, et al.
Published: (2025-07-01)

Efficacy of Inhaled Corticosteroids in Patients with Bronchiectasis without Airway Hyperresponsiveness: A Pilot Study
by: Safia Ahmed, et al.
Published: (2024-11-01)

Principles of Diagnosis and Therapy of Bronchial Asthma in Children at the Present Stage: GINA 2014–2015 Review Updates
by: L. R. Selimzyanova, et al.
Published: (2015-10-01)

Exploring the Insights and Interventions for Barriers to Adherence in Bronchial Asthma Treatment through a Patient-centered Approach
by: Pritama Paul, et al.
Published: (2024-07-01)

Impact of Co-Spray Drying with Leucine or Trileucine on Aerosol Performance, In Vitro Dissolution, and Cellular Uptake of Colistin Powder Formulations for Inhalation
by: Yijing Huang, et al.
Published: (2025-02-01)

Elevated Fracture Risks in Patients Using Inhaled Corticosteroids: A Korean Nationwide Study
by: Sung Hye Kong, et al.
Published: (2025-02-01)

A novel multi-drugs ciprofloxacin-curcumin-N-acetylcysteine co-delivery system based on hybrid nanocrystals for dry powder inhalations
by: Yingying Ma, et al.
Published: (2024-01-01)

Pulmonary delivery of insulin by dry powder inhaler formulations
by: Mohsen Imenshahidi, et al.
Published: (2025-07-01)

Biologics as well as inhaled anti-asthmatic therapy achieve clinical remission: Evidence from the Severe Asthma Network in Italy (SANI)
by: Giorgio Walter Canonica, MD, et al.
Published: (2025-01-01)

Development and Characterization of Spray-Dried Combined Levofloxacin–Ambroxol Dry Powder Inhaler Formulation
by: Ruwani K. Suraweera, et al.
Published: (2024-11-01)

Development of Mannitol-Based Microparticles for Dry Powder Inhalers: Enhancing Pulmonary Delivery of NSAIDs
by: Petra Party, et al.
Published: (2025-06-01)

Inhalation technique assessment and evaluation for the need of pharmaceutical intervention in respiratory pathologies patients
by: Paloma Castellano-Copa, et al.
Published: (2019-11-01)

Navigating the Development of Dry Powder for Inhalation: A CDMO Perspective
by: Beatriz Noriega-Fernandes, et al.
Published: (2025-03-01)

Influence of inhalation device, active substance, and drug formulation on the compliance of patients with obstructive pulmonary diseases. A physicians’ perspective
by: S.G. Theodorakis, et al.
Published: (2023-01-01)

Expression of circulating angiotensin‐converting enzyme 2 in children with asthma and the effects of inhaled corticosteroids
by: Xiang Ma, et al.
Published: (2023-07-01)

Modern Strategies for the Therapy of Persistent Bronchial Asthma in Adolescents
by: Еlena А. Dobrynina, et al.
Published: (2017-12-01)

Utilization and access to metered-dose inhalers and sustainable alternatives among older adults in the United States: a population-based studyResearch in context
by: Ashwaghosha Parthasarathi, et al.
Published: (2025-07-01)

Understanding mild asthma/episodic asthma in children
by: Robin Green
Published: (2007-04-01)

Optimising Asthma Self-Management: Preliminary Validation of an Arabic Version of the Inhaler Technique Questionnaire
by: Malath Al-Juhaishi, et al.
Published: (2025-01-01)

Surfactant therapy as a part of comprehensive treatment of asthma patients. Impact on clinical signs and external respiration rates
by: O. A. Rozenberg, et al.
Published: (2018-10-01)

2024 Update on Position Statement by Experts from the Polish Society of Allergology and the Polish Respiratory Society on the Evaluation of Efficacy and Effectiveness of Single Inhaler Triple Therapies in Asthma Treatment
by: Paweł Śliwiński, et al.
Published: (2024-10-01)